Executive record

Amir Reichman

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:amir-reichmanVersion: public-0As of: 2026-09-28

Not yet claimed5 published Claims1 sources

Key Claims

Biography

Former Head of Global Vaccines Engineering Core Technologies at GSK Vaccines and Senior Director of Vaccines Supply Chain. Holds M.Sc. in Biotechnology Engineering and MBA in Finance and Health Care Management from Wharton.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. 2023 to end not publishedExecutive title: Chief Executive Officer and Director · Organization not publishedSCNI 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. SCNI 10-K executive officers

    sec filing · Source published: Apr 17, 2023 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Scinai Immunotherapeutics Ltd. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Executive Officer and Director · Claim reviewed: May 16, 2026
    • Technology background: Technology background reported in filings · Claim reviewed: May 16, 2026